EPS PerformanceNon-GAAP EPS came in at $1.10, exceeding both the internal estimate and the consensus estimate of $1.02.
Investment RatingAnalyst maintains an OUTPERFORM investment rating on HAE shares with a price target of $86, indicating strong future potential.
Revenue PerformanceThe hospital segment is expected to deliver $148.4 million in revenue, marking a 7.2% increase compared to the same period a year ago.